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 ABSTRACT 
 
OBJECTIVE: The objective of this selective EBM review is to determine whether or not 
electrical muscle stimulation is effective in the progression of oral feeding, for patients with 
dysphagia, caused by a stroke.  
 
STUDY DESIGN: Review of 3 randomized controlled trials, published between 2008-2009. 
 
DATA SOURCES: All 3 randomized controlled trials were found using the Cochrane database.  
 
OUTCOMES MEASURED: All 3 studies measured subjective swallowing function pre- and 
post-treatment, however, each trial differed in the way they measured this. Permsirivanich et al 
used a functional oral intake scale (FOIS), or a 7-point scale reflecting the patient’s report of 
foods safely ingested by mouth, on a consistent basis.  Bulow et al determined swallowing 
function using an alternate 7-point scale, called the actual nutrition scale (ANS). Lim et al 
measured swallowing function using a third, unnamed, 7-point scale. The percentage of patients 
progressing from tube feeding to oral feeding was also measured in Lim et al. 
 
RESULTS: Bulow et al
 
concluded that no statistically significant difference was found in the 
therapy effects between neuromuscular electrical stimulation (NMES) and traditional therapy 
(TT) groups, however, when looking at both groups as a whole, there were significant 
improvements noted. In Permsirivanich et al, both rehabilitation swallowing therapy (RST) and 
NMES therapy (combined with diet modification and oral motor exercises) showed positive 
effects in the treatment of persistent dysphagia in stroke patients, but NMES therapy was 
significantly superior. Finally, in Lim et al, NMES combined with thermal tactile stimulation 
(TTS) had a significantly higher score change in swallowing measures (indicating a progression 
of oral feeding) than those receiving TTS alone.
 
 
CONCLUSION: As indicated by the 3 studies, NMES therapy, as an adjunct treatment to 
standard dysphagia treatment, is an effective intervention in the progression of oral feeding, in 
patients with dysphagia, caused by a stroke. Further studies should be performed to determine if 
NMES is a valuable therapy alone, or only advantageous when paired with a traditional therapy. 
 
KEY WORDS: “dysphagia”, “stroke”, “electrical muscle stimulation” 
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INTRODUCTION:  
The seemingly simple act of swallowing is actually a very complex process that is 
initiated by the cerebral cortex and followed through by the brain stem.  When these specific 
areas of the brain are injured, such as in a stroke, the act of swallowing is disrupted (known as 
dysphagia) and the airway becomes vulnerable.
1
 In fact, 45-65% of all acute stroke patients, 
which accounts for approximately 3.3 million healthcare visits annually
2
, will develop 
dysphagia.  Dysphagia leaves patients at risk for aspiration, because the muscles and nerves 
surrounding the oropharynx are not able to aid in safely transporting food from the mouth into 
the stomach. Aspiration can then lead to aspiration pneumonia, which accounts for 
approximately 34% of stroke related deaths, as well as causing complications such as choking, 
bronchospasm, increased infection rate, dehydration and nutritional compromise.
1 
Dysphagia can 
also have a negative social impact and thus affect one’s quality of life.  
 While the majority of stroke survivors have a return to normal swallowing function fairly 
rapidly after a cerebral vascular accident, this is not always the case, and thus healthcare 
providers must recognize the high healthcare costs of stroke survivors suffering from dysphagia.  
While it is not known what the exact healthcare costs may be, it has been proven that dysphagia 
after stroke lengthens hospital stays, thus carrying substantial economic burdens.  In fact, Altman 
et al
3
 found that in patients with hemorrhagic stroke, hospital stays increased from 4.74 days, in 
those without dysphagia, to 10.55 days, in those suffering from dysphagia.
  
Obviously, the longer 
the hospital stay, the greater the cost.
 
 Fortunately, the majority of healthcare workers are aware of dysphagia and its negative 
impact on one’s health, as well as its economic burden, thus, making it a topic of study in the 
medical community. Presently, there are a few successful methods used to treat dysphagia post- 
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CVA. Diet modification and specific exercises designed to strengthen the muscles surrounding 
the swallowing apparatus are two simple methods currently used.
4
 Thermal-tactile stimulation  
(TTS), which involves stroking a patient’s anterior faucial pillars with a cold probe prior to 
swallowing, is an alternate technique used.
1
 Yet another approach is rehabilitation swallowing 
therapy (RST), which includes supraglottic swallowing, effortful swallowing and the 
Mandelsohn maneuver, or purposeful prolongation, mid-swallow, of anterosuperior laryngeal 
traction.
5
 Current research is proposing electrical muscle stimulation, or neuromuscular electrical 
stimulation (NMES), which uses electrodes to deliver electrical stimulation to muscles, in turn 
causing muscle contraction by the depolarization of nerve fibers, and an increase in muscle 
strength, to aid in the treatment of dysphagia.
1
 A few studies have shown favorable effects of 
NMES on the symptoms of dysphagia, including reorganization of the human motor cortex, but 
studies are still being preformed on how pharyngeal function is truly affected by NMES.
4
 This 
review analyzes three randomized controlled trials which address NMES therapy versus control 
therapy, in the progression of oral feeding, in stroke patients suffering from dysphagia. 
OBJECTIVE: 
The objective of this selective EBM review is to determine whether or not electrical 
muscle stimulation is effective in the progression of oral feeding, for patients with dysphagia, 
caused by a stroke. 
METHODS: 
The studies included in this review were found within the Cochrane database, after 
preforming an advanced search with the following parameters: only articles published in English, 
studies published after 2006 and the exclusion of previously published meta-analysis or 
systematic reviews. The key words “dysphagia”, “stroke” and “electrical muscle stimulation” 
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were used to search for relevant studies. Published articles were then selected based on relevance 
to the topic and how the outcomes were measured: disease oriented evidence (DOE) was 
excluded, while patient oriented evidence that matters (POEM) was included. Inclusion criteria 
comprised of stroke survivors who were medically stable and able to elicit some pharyngeal 
swallowing. Exclusion criteria included patients with neurologic disease other than a stroke, as 
well as patients unable to receive treatment for a minimum of 1 hour in duration. Furthermore, 
the studies needed to be randomized and controlled and could not involve patients under 18 years 
old, or involve patients with dysphagia not caused by a stroke.  
 The 3 articles chosen for this review are all randomized controlled trails, each of which 
compare the efficacy of NMES alone or with diet modification and/ or oral motor exercises, 
versus a traditional therapy. The intervention in each study is electrical muscle stimulation, while 
the comparisons are traditional therapies (including TTS, RST, diet modification, clinician 
determined appropriate maneuvers or other treatment techniques). The outcomes measured 
include either subjective swallowing function or tube to oral feeding progression, post- therapy. 
The population studied across all three articles is adults over 18 years of age with mild to severe 
dysphagia caused by a stroke. A summary of the statistics reported or used includes: p-values, 
RBI, ABI and NNT. The demographics of included studies can be found in Table 1.  
Table 1: Characteristics and Demographics of Included Studies. 
Study Type # 
of 
pts 
Age Inclusion criteria Exclusion criteria W/D Interventions 
Bulow
4
 
(2008)
 
RCT 25 50-80 
(mean 
age 70 
for 
NMES 
and 71 
for TT 
group) 
-Patients 50-80 y/o 
with CVD >3 
months prior to the 
study 
-Patients with 
hemispheric stroke 
and without 
neurologic signs 
-Patients with 
progressive CVD, 
other neurologic 
diseases or neoplastic 
disease of the 
swallowing apparatus 
and radiotherapy to 
the neck 
N/A Neuro-
muscular 
electrical 
stimulation 
(NMES), 
using a hand-
held electrical 
stimulator 
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typical for brainstem 
involvement 
-Patients had to be 
able to elicit some 
pharyngeal 
swallowing 
-Patients had to be 
able to communicate 
-Patients who had 
undergone surgery to 
the swallowing 
apparatus 
-Patients who were 
not able to elicit 
pharyngeal swallow 
-Patient with an NG 
tube 
(VitalStim®), 
for one-hour 
sessions, 5 
days a week 
for 3 weeks, 
compared to 
TT. 
 
Permsiri
vanich
5
 
(2009)
 
Single 
blind 
RCT 
23 >18 
(64.73 
+ 9.39 
for 
RST; 
64.50+ 
8.80 
for 
NMES
) 
-Hospitalized stroke 
survivors with 
persistent dysphagia 
for > 2 weeks 
between November 
2007 and September 
2008. 
-Video-fluoroscopic 
study (VFSS) 
finding that 
indicated pharyngeal 
dysphagia with safe 
swallowing  
N/A 5 NMES, via 
VitalStim®, 
combined with 
diet 
modification 
and oral motor 
exercise, done 
for 1 hour 
sessions, for 5 
consecutive 
days with 2 
days off for 4 
week, 
compared to 
RST.  
Lim
1 
(2009)
 
RCT 28 >18  
(mean 
SD: 
67.8 
(8.1) 
for 
exp; 
60.8 
(12.3) 
for 
control
) 
-Primary diagnosis 
of stroke with MRI 
or CT scans 
-Confirmation of a 
swallowing disorder 
by videofluoroscopy 
-Score of 21 or 
greater on the 
MMSE 
-Medically stable at 
the time of the study 
-Inability to receive 
the treatment for 1 
hour 
-A neurologic disease 
other than a stroke or 
behavioral disorder 
that interfered with 
administration of 
therapy 
-Current illness or 
upper GI disease 
-Inability to give 
informed consent  
8 NMES, via 
VitalStim®, 
and TTS for 1 
hour, 5 days a 
week, 
compared to 
TTS alone.  
 
OUTCOMES MEASURED: 
 As previously mentioned, the primary outcomes measured in each article included either 
subjective swallowing function or tube to oral feeding progression. In Bulow et al
4
, nutritional 
status via a 7-point scale, called the actual nutrition scale (ANS), was used to assess outcomes. 
The 7-point scale is as follows: 0= full oral, no limitations; 1= full oral, with compensation; 2= 
full oral, with consistency restriction; 3= full oral, with compensation and consistency restriction; 
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4= partial oral; 5= partial oral, with compensation; 6= tube feeding. In Permsirivanich et al
5
, 
outcomes were assessed based on changes in functional oral intake via the Functional Oral Intake 
Scale (FOIS), a 7-point scale reflecting the patient’s report of food/ liquids safely ingested by 
mouth on a consistent basis. The FOIS scale is as follows: 1= nothing my mouth; 2= tube 
dependent with minimal attempts of food or liquid; 3= tube dependent with consistent oral intake 
of food or liquid; 4= total oral diet of a single consistency; 5= total oral diet with multiple 
consistencies but requiring special preparation; 6= total oral diet with multiple consistencies 
without special preparation, but with specific food limitations; 7= total oral diet with no 
restriction.  Finally, Lim et al
1
 looked at both tube feeding to oral progression and swallowing 
function, via an alternate 7 point scale, which is as follows: 0= nothing safe (aspirated saliva); 1= 
saliva; 2= pudding, paste, ice slush; 3= honey consistency; 4= nectar consistency; 5= thin 
liquids; 6= water. 
 
RESULTS: 
 The results obtained in all three studies were presented as continuous data. In 
Permsirivanich et al
5 
and Lim et al
1
, some of the data could be successfully converted to 
dichotomous form. However, this was not a possibility in Bulow et al
4
. 
The study conducted by Bulow et al
4
 used the ANS mentioned above to compare 
traditional swallowing therapy (TT), conducted for 60 minutes, 5 days a week for 3 weeks versus 
NMES done for 60 minutes, 5 days a week for 3 weeks.  Twenty-five patients over the age of 18 
were included, with 12 randomized to the NMES group and 13 to TT.  All subjects received 15 
therapy sessions, regardless of the group they were randomized to. There was not a significant 
loss to follow-up in this study, which indicates a loss of < 20%. Table 2, taken directly from 
Bulow et al
4
, summarizes the results, which compares median (as well as 25
th
 and 75
th
 percentile) 
Iaconelli, Dysphagia Post-Stroke and EMS, 6 
 
 
pre- and post-treatment ANS scores. The data is continuous and could not be converted to 
dichotomous data.  The median post-treatment minus pre-treatment ANS score was 0 for NMES 
plus TT therapy, as well as TT therapy alone, and -1 for NMES therapy alone. Using the 
Wilcoxon signed rank test to examine this data, Bulow et al
4
 found the data to be statistically 
significant, with a p-value of .002 (a p-value < 0.05 indicates statistical significance). However, 
when the therapy effects between the NMES group and the TT group were compared using the 
Mann-Whitney test, there were no statistically significant differences found between the groups, 
as indicated by a p-value of 0.189. 
4 
Table 2: Actual nutrition scale (ANS), comparisons pre- and post-treatment
4 
*ns= not significant  
In Permsirivanich et al
5
, change in functional oral intake was measured using the 
functional oral intake scale (FOIS), mentioned above, in order to compare treatment outcomes 
between RST and NMES intervention in stroke patients. Twenty-three patients enrolled in the 
study were randomly split into a RST group of 11 and a NMES group of 12. While there were 
originally 28 patients enrolled in the study, the losses (18%) did not constitute a significant loss. 
All subjects received 60 minutes of either RST or NMES for 5 consecutive days, followed by 2 
days off, then 5 additional consecutive days for a four-week period, until they reached a FOIS 
level of 7.  The summary of results can be found in Table 3 & Table 4. Table 3 illustrates 
continuous data that was converted to dichotomous data. The data in Table 3, which uses the 
percent of patients who managed total oral intake after therapy, in the RST (75%) versus the 
NMES (90%) group, to determine relative benefit increase (RBI), absolute benefit increase 
ANS Pretreatment Post minus pre-treatment p
a 
 Median 25
th
; 75
th
 N Median 25
th
; 75
th
 N  
NMES 2.5 0.5; 5.8 12 -1.0 -2.0: 0 12 0.189 (ns) 
TT 3.0 0; 5.0 13 0 -1.0; 0 13  
NMES + 
TT 
3.0 0: 5.0 25 0 -1.0: 0 25 0.002 
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(ABI) and number needed to treat (NNT) does indicate that treating 7 patients with dysphagia 
post-stroke with NMES therapy, compared with RST, will have 1 additional patient achieve total 
oral intake (as noted by the NNT of 7).   
Permsirivanich et al
5
 also included mean FOIS score changes, post-treatment, for the 
RST and NMES groups, which was presented as continuous data, as seen in Table 4. Using a t-
test, the mean FOIS changes, for both the RST and NMES groups, were determined to be 
statistically significant (p< .001), with the NMES therapy group attaining a greater mean FOIS 
score change of 3.17 + 1.27 versus 2.46 + 1.04 in the RST group. 
Table 3: Percentage of patients who managed total oral intake (FOIS levels 4-7) after therapy. 
 
Total oral intake (FOIS levels 4-7) after 
therapy. 
Relative Benefit 
Increase (RBI) 
Absolute Benefit 
Increase (ABI) 
Numbers Needed to 
Treat (NNT) 
RST  NMES    
75% 90% 20% 15% 7 
 
Table 4: Mean FOIS score change post-treatment.
5 
 
Total oral intake (FOIS levels 
4-7) 
RST NMES therapy p-value 
Mean FOIS change 2.46 + 1.04 3.17 + 1.27 <0.001 
 
Finally, in Lim et al
1
, swallow function scores, based on the swallowing function scoring 
system mentioned above, were calculated 4 weeks prior to treatment and 4 weeks post-treatment 
for both the experimental group (NMES & TTS simultaneously) and the control group (TTS 
only). The therapy sessions in both groups lasted for 1 hour on 5 of 7 days each week. Thirty-six 
subjects entered the study, while 28 patients (16 in the experimental group and 12 in the control 
group) with dysphagia completed the study, making the losses to follow-up > 20%, and thus a 
significant loss. Lim et al
1
 stated that the main reason for patients not completing the study was 
“early transfer to other hospital”.  Table 5, taken directly from Lim et al1, includes a summary of 
the initial, final and difference in the median swallow function scores, for the experimental and 
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control group.  While the table indicates a difference in the median initial swallow scores for the 
control and experimental group (2 in the experimental versus 3 in the control), Lim et al
1
 states 
“there was no difference between the 2 groups at initial evaluation”. However, it is evident in 
Table 5, that the median value of swallow function scores in the experimental group changed 
from 2 to 4, with a p-value <0.05 (as indicated by the Wilcoxon test), signifying a statistically 
significant difference, while the control group changed from 3 to 4, with a p-value that was not 
reported but stated to be “not significant”. As the study explains, “regarding the difference 
between the initial and final swallow function score, patients in the experimental group had 
significantly higher score changes than those in the control group”. 
Tube feeding to oral-feeding progression was another parameter studied by Lim et al
1
. 
Before the experiment, 7 out of 12 patients in the control group, and 12 out of 16 patients in the 
experimental group, were receiving tube feeds. Following the respective interventions, only 1 of 
the 7 patients in the control group progressed to oral feeds, while 6 out of the 12 patients in the 
NMES & TTS group progressed. While this data was reported as continuous numbers in the 
study, it was switched to dichotomous data for this review, as noted in Table 6.  NNT was 
calculated at 3, indicating that treating 3 patients with dysphagia post-stroke with NMES & TTS 
combined compared with TTS alone will have 1 additional patient achieve progression from tube 
to oral feeding, at 4 weeks after treatment.
 
Table 5: Median swallow function scores, using the swallowing function scoring system.
1 
Swallow Scores Experimental Group Control Group 
Initial swallow scores 2 3 
Final swallow scores 4* 4 
Difference in scores 
after the treatment 
2** 1 
*p<0.05 by Wilcoxon test between initial and final scores in the same group. 
**p<0.05 by Mann-Whitney U test between experimental and control groups. 
 
Table 6: Tube to oral feeding. 
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Tube to oral feeding. 
 
RBI ABI NNT 
TTS alone NMES & TTS    
14% 50% 25.7% 36% 3 
 
It is important to note that NMES therapy is a relatively safe intervention, with few 
significant adverse reactions (more information regarding this can be found in the discussion 
section below). Thus, the studies reviewed for this analysis did not mention much regarding 
tolerability, or adverse events of therapy, and therefore will not be discussed here. 
DISCUSSION:   
 The goal of this review was to investigate whether or not NMES therapy is effective in 
the progression of oral feeding, in patients with dysphagia, caused by a stroke. Traditional 
NMES therapy is perhaps most widely known for its role in muscle rehabilitation, post-injury, 
because it helps to produce muscle contractions by exciting targeted motor nerves. Some of the 
common conditions NMES is used for include sprains, strains, muscle weakness and atrophy. 
The presence of healthy muscle tissue and peripheral nerve excitability are necessary in order to 
produce therapeutic effects for these individuals.
6 
This same thought process is applied when 
considering NMES for dysphagia. In dysphagia treatment, small, electrical impulses are 
administered to the musculature overlaying the throat, while the patients exercises the 
swallowing muscles, for up to 1 hour. It is postulated that this stimulation accelerates cortical 
reorganization and increases muscle strength.  However, traditional NMES electrodes are 
contraindicated for use on the pharyngeal muscles due to the concern of causing laryngospasms 
with stimulation of the laryngeal afferents, and the threat of sinus bradycardia if the electrodes 
are too close to the carotid arteries.
7
 Therefore, electrodes, such as those found in the VitalStim® 
Therapy System, have been developed for use specifically in the treatment of dysphagia.  These 
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electrodes should not be used over an active infection or neoplasm, and should be used 
cautiously in individuals with seizure disorders or implanted electrical devices like pacemakers, 
defibrillators, deep brain stimulators, etc. Furthermore, patients with lower motor neuron damage 
or severely impaired cognition may not benefit as well as other patients from NMES treatment.
7 
It is also important to note that NMES therapy for dysphagia is FDA approved, and Medicare 
provides reimbursement for treatment that is deemed medically necessary.
7 
Despite a lack of evidence, studies are currently being preformed, such as the 3 
mentioned in this article, to better understand the role of NMES in the treatment of dysphagia, 
caused by a stroke. NMES appears to play a significant role in the progression of oral feeding in 
stroke patients suffering from dysphagia, yet its efficacy when used alone in treatment remains 
unclear. Bulow et al
4 
concluded that no statistically significant difference was found in the 
therapy effects between NMES and TT groups, however, when looking at both groups as a 
whole, there were significant improvements noted. In Permsirivanich et al
5
, RST (including diet 
modification, oral motor exercises, thermal stimulation and head and neck positioning) and 
NMES therapy (combined with diet modification and oral motor exercises) showed a positive 
effect in the treatment of persistent dysphagia in stroke patients, but NMES was significantly 
superior. Finally, in Lim et al
1
, NMES combined with TTS  (vs. TTS alone) had a significantly 
higher score change in swallowing measures, than those in the control group.
 
In all 3 studies reviewed, there were several limiting factors, however. All articles
1,4,5
   
included a relatively small number of subjects, with each comprising of less than 30 participants 
by the conclusion of the studies. Furthermore, the length of follow up time was limited in all 
studies
1,4,5
, with a 4 week or less follow-up period. More specific limitations were also found in 
each individual study.  In Bulow et al
4
, the authors indicated that patients were not stratified by 
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hemispheric lesion, severity of CVA or time post-onset, which could have an effect on the 
results. It can also be noted that although randomized, the baseline data for the NMES group was 
more severe than those in the TT group. In Permsirivanich et al
5
, the number of total treatment 
sessions, as well as the location of the NMES electrode placement, were not controlled for. In 
Lim et al
1
, the participants loss to follow up was greater than 20%, undermining the validity of 
the study. Also, the effects of swallowing physiology of changing variables of electrical 
stimulation, like frequency and amplification, were not taken into account.
 
CONCLUSIONS: 
 In conclusion, electrical muscle stimulation is subjectively effective in the progression of 
oral feeding, in stroke patients suffering from dysphagia, according to the three studies explored 
in this paper. However, there is inconclusive evidence as the whether or not NMES therapy is 
effective alone, or only in combination with TT, as demonstrated by Bulow et al
4
, or combined 
with TTS, as seen in Lim et al
1
. Further studies should consider controlling for these variables by 
having the experimental group receive only NMES therapy, versus NMES in combination with 
another traditional therapy. 
 Furthermore, the validity of the results could be increased with a greater number of 
subjects, as well as with long-term follow-up periods.  Future studies might also consider 
exploring the optimal duration time of each session, as well as total number of sessions for 
NMES therapy, that would lead to optimal progression of oral feeding.  Furthermore, it might be 
interesting for future studies to evaluate the effect of variable frequencies and amplitudes of 
NMES on swallowing physiology, just as Permsirivanich et al
5 
mentions.
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